companydata.dkcompanydata.dk

TJ Biotech Holding ApS: Financial statements 2023

CVR: 41953616

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 70,004 and a net result of DKK -9,513,527 compared with DKK -215,772 the year before. That is an increase of 30.7% compared with the year before. Equity in the 2023 report amounted to DKK 13,754,831. The solvency ratio was 75.8%.

Gross Profit
DKK 70,004
Profit/Loss
DKK -9,513,527
Equity
DKK 13,754,831
Total Assets
DKK 18,140,481
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-70K-9.5M13.8M0
2022-54K-216K23.3M0
2021-1.7M413K23.5M1
2020-1.4M90K23.1M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

TJ Biotech Holding ApS: The 2022 annual report is outJul 3, 2023

TJ Biotech Holding ApS has published its annual report for 2022. Gross profit came to DKK 53,543, and the net result was DKK -215,772.

About TJ Biotech Holding ApS

TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.

Source: annual report 2025, Danish Business Authority

Other financial years